ArticleJournal for immunotherapy of cancer2025

Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma.

Muqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.